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RESEARCH ARTICLE Open Access
Potential role for PADI-mediated histone
citrullination in preimplantation development
Rui Kan1, Mei Jin1, Venkataraman Subramanian2, Corey P Causey3, Paul R Thompson2 and Scott A Coonrod1*
Abstract
Background: The peptidylarginine deiminases (PADIs) convert positively charged arginine residues to neutrally
charged citrulline on protein substrates in a process that is known as citrullination or deimination. Previous reports
have documented roles for histone citrullination in chromatin remodeling and gene regulation in several tissue
types, however, a potential role for histone citrullination in chromatin-based activities during early embryogenesis
has not been investigated.
Results: In the present study, we tested by laser scanning confocal indirect immunofluorescence microscopy
whether specific arginine residues on the histone H3 and H4 N-terminal tails (H4R3, H3R2 + 8 + 17, and H3R26) were
citrullinated in mouse oocytes and preimplantation embryos. Results showed that all of the tested residues were
deiminated with each site showing a unique localization pattern during early development. Given these findings,
we next tested whether inhibition of PADI activity using the PADI-specific inhibitor, Cl-amidine, may affect
embryonic development. We found that treatment of pronuclear stage zygotes with Cl-amidine reduces both
histone H3 and H4 tail citrullination and also potently blocks early cleavage divisions in vitro. Additionally, we found
that the Cl-amidine treatment reduces acetylation at histone H3K9, H3K18, and H4K5 while having no apparent
effect on the repressive histone H3K9 dimethylation modification. Lastly, we found that treatment of zygotes with
trichostatin A (TSA) to induce hyperacetylation also resulted in an increase in histone citrullination at H3R2 + 8 + 17.
Conclusions: Given the observed effects of Cl-amidine on embryonic development and the well documented
correlation between histone acetylation and transcriptional activation, our findings suggest that histone citrullination may
play an important role in facilitating gene expression in early embryos by creating a chromatin environment that is
permissive for histone acetylation.
Keywords: Peptidylarginine deiminase, Citrullination, Histone modification, Preimplantation development, Cl-amidine
Background
The fundamental repeating unit of chromatin is the nucleo-
some that contains two superhelical turns of DNA wrapped
around an octamer of two copies each of the core histones
H2A, H2B, H3 and H4 [1,2]. Resolution of the nucleosome
structure revealed that the N-terminal histone tails
protrude from the nucleosomal core in an unstructured
manner [3] and contain an ever-growing number of post-
translational modifications such as acetylation, methylation,
phosphorylation, and more recently, citrullination [4,5]. Im-
portantly, these modifications, or “marks”, play critical roles
in many cellular functions, including DNA replication, con-
densation, and repair, as well as gene regulation [6]. Of
these modifications, histone acetylation is perhaps most
strongly associated with gene regulation. Increasing levels
of histone acetylation are correlated with a transcriptionally
permissive state whereas deacetylated histone are closely
associated with transcriptional repression [7]. Histone
acetylation is also implicated in the activation of embryonic
gene expression in preimplantation embryos [8]. For ex-
ample, previous reports investigating late two-cell embryos
have found that inducing histone hyperacetylation with
HDAC inhibitors stimulates global transcription [9] and
depletion of HDAC1 by RNAi results in elevated levels of
specific gene targets [8]. Previous studies in somatic cells
have demonstrated that specific histone modifications can
directly affect the levels of other marks and this interplay
leads to a complex mechanism of gene regulation, fre-
quently referred to as the “histone code” [10,11]. While
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fewer of these types of studies have been carried out in
early embryos, several reports have found that cross-talk
exist between histone acetylation and histone methylation
in normal and cloned embryos [12].
PADI enzymes are increasingly being associated with
the regulation of chromatin structure and gene activity
via histone citrullination. For example, we have found
that PADI4-mediated citrullination of histone H4 argin-
ine 3 at the TFF1promoter in MCF7 cells appears to
regulate the expression of this canonical estrogen recep-
tor target [13]. Others have shown that PADI4-mediated
histone citrullination plays a role in regulating other tar-
get genes such as TRP53 and OKL38 [14,15]. In addition
to PADI4, we recently found that PADI2 localizes to the
nucleus of mammary epithelial cells and appears to tar-
get histone H3 for citrullination [16], thus suggesting
that multiple PADIs regulate chromatin-based activities.
We have previously documented that oocyte -and-
embryo abundant PADI6 is required for female fertility,
with PADI6-null embryos arresting at the two-cell stage
of development [17]. Given the growing body of litera-
ture linking PADI enzymes to histone citrullination and
the abundance of PADI6 in oocytes and early embryos,
we first tested whether histones were citrullinated in
oocytes and preimplantation embryos. Next, we treated
embryos with the PADI-specific inhibitor, Cl-amidine, to
confirm that the observed citrulline marks were gener-
ated by PADI activity and also to test whether inhibition
of PADI activity may affect preimplantation development
in vitro. Lastly, to gain insight into potential mechanisms
by which histone citrullination may regulate gene activ-
ity, we tested whether inhibition of PADI activity in early
embryos affects histone acetylation and whether induc-
tion of histone hypoacetylation affected levels of histone
citrullination. Findings from this study are discussed
below.
Results and discussion
Citrullination of histone H3 and H4 tails in oocytes and in
preimplantation embryos appears to be robust and
dynamic
In the present study, the status of histone H3 and H4
citrullination during early development was investigated
by staining fully grown mouse germinal vesicle (GV)
stage oocytes and preimplantation embryos with three
site-specific citrullinated histone antibodies: anti-histone
H4 citrulline 3 (H4Cit3), anti-histone H3 citrulline 2, 8,
and 17 (H3Cit2 + 8 + 17) and anti-histone H3 citrulline
26 (H3Cit26) [13,16,18]. Results from these confocal in-
direct immunofluorescence studies showed that H4Cit3
staining was observed in the nucleus and cytoplasm of
oocytes and early embryos at interphase. Interestingly,
the strongest staining for this citrulline modification
appears to occur on mitotic metaphase chromatin,
suggesting that H4Cit3 may play a role in chromatin
condensation or decondensation at metaphase
(Figure 1A). Staining with the anti-H3Cit2 + 8 + 17 anti-
body found that this modification also stained nuclei
during interphase (Figure 1B). However, at metaphase,
this antibody appeared to primarily stain the spindle ap-
paratus (Figure 1B; arrows in the panel of anaphase II)
and a structure at opposed regions of two cell blasto-
meres that appears to be the microtubule-containing
mid-body [19,20] (Figure 1B; arrowheads in panels of 2-
cell). Interestingly, in somatic cells, an anti-phospho-H3
serine 10 antibody detected histones with this modifica-
tion at the anaphase spindle apparatus and at the mid-
body during cytokinesis [21]. These investigators specu-
lated that this modification may mark histones for
removal from the nucleosome or possibly that this modi-
fied histone may actually play a direct role in cytokinesis
by functioning at the mid-body [22]. It is currently not
known whether citrullinated histones in the cytoplasm
of oocytes and early embryos might have a similar func-
tion. Alternatively, however, it is also possible that the
observed spindle and mid-body staining with the
H3Cit2 + 8 + 17 antibody is non-specific in nature.
The staining pattern observed with the anti-H3Cit26
was perhaps the most interesting of all. Results found
that both oocytes and early embryos showed a strong
punctate cytoplasmic signal that appeared to coalesce
into larger aggregates as the embryos developed
(Figure 1C) and these foci appeared by light microscopy
to be lipid droplets. To test this hypothesis we stained
mutant MATER GV oocytes (which have elevated levels
of lipid droplets [18]) with Nile Red or with the H3Cit26
antibody. Results show (Additional file 1) that the
H3Cit26-containing cytoplasmic foci clearly appear to be
lipid droplets. Interestingly, a recent study found that
lipid droplets in Drosophila embryos are maternally-
derived and that these structures contain ~50% of all
embryonic histones. This finding suggests that the lipid
droplets function to sequester maternal histones in the
early embryo until they are needed for chromatin-based
activities [19]. An intriguing possibility is that the
H3Cit26 modification marks histones for lipid droplet
storage and/or possibly shuttling histones between lipid
droplets and the nucleus. H3Cit26 staining within the
nucleus was also interesting; whereas little to no signal
was seen in GV stage oocytes, strong staining was
observed on the outer margins of both male and female
pronuclei and around the nucleoli of two-cell embryos
(Figure 1C; arrows in panels of 2-PN and 2-cell). By the
four-cell stage of development no nuclear staining was
observed. Given that embryonic genome activation is
known to initiate at the late pronuclear/early two-cell
stage, this observation raises the possibility that this
particular citrulline modification may play a role in
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activation of the embryonic genome. Taken together, our
data raise the possibility that the different histone modi-
fication sites may play different roles in preimplantation
development.
Given that each of these anti-citrullinated histone anti-
bodies showed both cytoplasmic and nuclear localization
patterns, we next confirmed the specificity of our anti-
bodies by testing whether pre-absorption of the antibodies
with their cognate peptide affected indirect immunofluor-
escence signal intensity levels (Additional file 2). Results
showed that peptide preabsorption suppressed the fluores-
cence intensity for each of the three antibodies (Additional
files 2A, 2B, and 2C, respectively). These results suggest
that the localization patterns observed for the H4Cit3,
H3Cit2+ 8+ 17, and H3Cit26 are specific.
Cl-amidine blocks mouse embryonic development
beyond the two to four cell stage in vitro
The above observations suggested that PADI-mediated
histone citrullination may play an important, previously
unknown, role in early development. Given that PADI6
is essential for early cleavage divisions, we next tested
whether levels of these modifications were reduced in
PADI6-null mouse oocytes/early embryos. We found
that loss of PADI6 did not appear to affect histone
citrullination levels (see Additional file 3A, 3B, and 3C).
Given PADI4’s previously documented roles in histone
citrullination and gene regulation [13,14], we then tested
citrullinated histone levels in PADI4-null oocytes. Again,
we did not observe any appreciable loss in levels of
citrullinated histone in this mutant line (see Additional
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Figure 1 Temporal and spatial distribution of histone H3 and H4 citrullination in oocytes and preimplantation embryos. A. Oocytes and
embryos were isolated from CD1 female mice, fixed, permeabilized, and immunolabeled with antibodies against H4Cit3 (red). B. Same as (A)
except anti-H3Cit2 + 8 + 17 antibodies (red) were used. Spindle apparatus and microtubule based mid-bodies are indicated by arrows and
arrowheads, respectively. C. Same as (A) except anti-H3Cit26 antibodies (red) were used. Nucleoli are denoted by arrows. All samples were
counterstained with 4′,6-diamidino-2-phyenylindole (DAPI) to visualize DNA (Blue). Cells were imaged by laser scanning confocal microscopy. DIC,
differential interference contrast. PN, pronuclear. Blast., blastocyst.
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file 4A and 4B). Together, these observations suggest,
neither PADI4 nor PADI6 catalyze these specific citrul-
line modifications on histones in oocytes or early
embryos.
Given these observations, and the lack of mutant PADI1,
PADI2, and PADI3 mouse lines, we next decided to test the
effects of a newly developed PADI inhibitor, Cl-amidine, on
histone citrullination and on early embryonic development.
Cl-amidine has been shown to irreversibly block the activity
of all PADI enzymes in vitro and has also been shown in
cell culture and mouse-based assays to functionally inhibit
PADI activity in vivo [20-22]. We first tested whether Cl-
amidine suppressed citrulline levels on histones in early
embryos using the H4Cit3, H3Cit2+8+17, and H3Cit26
antibodies. PN zygotes were cultured in KSOM media sup-
plemented without or with 250 μM of Cl-amidine. Embryos
at the 4-cell stage from KSOM and Cl-amidine groups were
fixed after being cultured for ~42 hours and ~68 hours, re-
spectively, to ensure developmental arrest at cleavage stage.
Next, the embryos were stained with the anti-citrullinated
histone antibodies and then evaluated by laser scanning
confocal microscopy. Results showed that staining levels for
the H4Cit3 and H3Cit2+8+17 antibodies was reduced,
compared with the KSOM control group (Figure 2A and
2B, arrows in top panels). Interestingly, however, Cl-
amidine treatment did not appear to affect levels of the
H3Cit26 modification, suggesting that histone citrullination
at this site may have occurred in oocytes prior to drug
treatment (Figure 2C). Actin levels and localization did not
appear to be affected by Cl-amidine. These results support
the hypothesis that the histone citrullination in embryos is
catalyzed by PADI activity.
We next investigated the effects of Cl-amidine on embry-
onic development in vitro. As a control for these experi-
ments, we also tested the effect of H-amidine on
development. This analog displays very weak PADI inhibi-
tory activity [31] with, for example, the IC50 values of Cl-
amidine and H-amidine for PAD4 inhibition in vitro being
5.9 μM and> 1000μM, respectively [31]. The structures of
these two compounds are shown in Figure 2D and 2E. PN
stage zygotes were cultured for ~68 hours in KSOM media
supplemented with 250 μM of either Cl-amidine or H-
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Figure 2 Cl-amidine blocks embryonic development in vitro at the 2 to 4 cell stage. A. Immunofluorescent confocal images showing that
Cl-amidine reduces citrullination at H4R3 in 4-cell embryos. PN stage zygotes were cultured for ~42 hours or ~68 hours in KSOM medium
supplemented without or with 250 μM of Cl-amidine. Four-cell embryos were fixed and immunostained with anti-H4Cit3 antibodies (red).
Phalloidin and DAPI were employed to detect F-actin (red) and DNA (blue). Arrows highlight H4Cit3 staining on chromatin. DIC, differential
interference contrast. B. Same as (A) except with anti-H3Cit2 + 8 + 17 antibodies. C. Same as (A) except with anti-H3Cit26 antibodies. D. Structure
of Cl-amidine. The red square highlights the chlorine group that is replaced with hydrogen to generate H-amidine. MW., Molecular weight. E.
Structure of H-amidine. F. Rate of development to the morula stage following Cl-amidine treatment. Pronuclear stage zygotes were cultured for
~68 hours in KSOM medium supplemented with 250 μM of Cl-amidine or H-amidine and observed by light microscopy. H-AM, H-amidine.
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amidine. The number and developmental stage of embryos
was then evaluated using light microscopy. Results showed
that embryos arrested either at the 2-4 cell stage (83%,
n=100) or at the 1-cell stage (17%, n=100) in the Cl-
amidine group, while 86.1% of embryos (n=94) in the H-
amidine group and 72.3% of embryos (n=36) in KSOM
medium alone developed to the morula stage (Figure 2F
and Table 1). We note here that (1) the concentration of
Cl-amidine used in our study is within the range of that
used to functionally block PADI activity in somatic cells
[14,23] and that (2) lower concentrations of Cl-amidine did
not affect embryonic development (Additional file 5A and -
5B). Our finding that Cl-amidine suppressed histone citrul-
lination in cleavage-stage embryos suggested that the
observed effects of Cl-amidine on development were due to
specific inhibition of PADI activity. However, it is also pos-
sible that the inhibitor blocked development because of
non-specific toxic side-effects. To address this possibility,
we first examined embryo viability following Cl-amidine
and H-amidine treatment using the vital dye propidium
iodide (PI). Results showed that nuclei from both Cl-
amidine and H-amidine treated (250 μM) embryos were
not stained with PI (20 μg/ml) while nuclei from embryos
that were treated with Cl-amidine and extracted with 0.1%
Triton were strongly stained with PI (Additional file 6A).
These results indicate that the plasma membrane of Cl-
amidine and H-amidine treated embryos appeared func-
tional. To further confirm embryo viability, we next evalu-
ated the mitochondrial membrane potential of Cl-amidine
and H-Amidine treated embryos using the JC-1 fluorescent
dye, which accumulates in functional mitochondria as red-
staining aggregates (Additional file 6B). Results showed that
the mitochondrial membrane potential appeared to be
similar between the Cl-amidine and H-amidine treatment
groups, suggesting the Cl-amidine does not affect mito-
chondrial health. Together, these findings suggest that
PADI activity is required for progression of embryonic de-
velopment beyond the two to four cell stage.
Treatment of embryos with C-amidine suppresses histone
H3 and H4 acetylation while having no apparent effect on
the repressive H3K9 Di-methyl modification
As noted, histone acetylation is well correlated with acti-
vation of gene expression in somatic cells and is also
believed to play an important role in modulating gene
expression in preimplantation embryos [7-9]. In order to
begin testing whether histone citrullination may play a
role regulating gene activity in early embryos, we tested
whether suppression of histone citrullination with Cl-
amidine affected levels of histone acetylation on H3 and
H4 tails. Results showed that Cl-amidine treatment sig-
nificantly reduced levels of histone H4 acetylation
(Figure 3A and 3E). The fluorescent intensities for hyper
acetylated H4 (hyper acH4) and H4K5 Acetyl (H4acK5)
in Cl-amidine, TSA, and KSOM groups were presented
in Figure 3B and 3F. Additionally, Cl-amidine also dra-
matically reduced the level of acetylation on the H3 tail,
namely H3K9 Acetyl (H3acK9) and H3K18 Acetyl
(H3acK18) (Figure 3A and 3C). The fluorescent inten-
sities for these modifications were showed in Figure 3B
and 3D. To gain further insight into the mechanisms by
which histone citrullination may regulate gene activity,
we also tested whether Cl-amidine affected levels of di-
methylated histone H3K9, a modification closely asso-
ciated with transcriptional repression [24]. We found
that levels of this modification were not significantly
affected by Cl-amidine treatment (Figure 3C and 3D).
To validate the specificity of the acetylated histone anti-
bodies, the embryos were also treated with the HDAC
inhibitor Trichostatin A (TSA), and as expected, staining
for acetylated histones (hyper acH4, H4acK5, H3acK9,
and H3ack18) was elevated following TSA treatment
(Figure 3). Taken together, these results suggest that in-
hibition of PADI-mediated histone citrullination sup-
presses histone acetylation.
Histone hyperacetylation promotes histone citrullination
in early embryos
To further explore the potential interplay between histone
citrullination and acetylation, the colocalization of citrulli-
nation at H3R2+8+17 and acetylation at H3K9 was tested
in 2-cell embryos. Results revealed that these two histone
modifications localize, in part, to different regions of the
nucleus, and they do appear to colocalize at specific foci in
2-cell embryos (Figure 4A, arrows highlight overlapping
regions which are seen as yellow in the overlay). To further
test whether there was a potential crosstalk between his-
tone citrullination and acetylation, levels of H3R2+8+17
citrullination were examined in embryos treated with either
TSA or Cl-amidine. To perform this experiment, PN
zygotes were recovered from B6D2F1/J females and cul-
tured in KSOM medium supplemented with either 100 nM
of TSA or 250 μM of Cl-amidine, respectively, for ~68
hours. Results showed that, as expected, levels of H3Cit2+
18+17 were significantly reduced following Cl-amidine
treatment (Figure 4B-C). Interestingly, however, we found
that induction of histone hyperactylation via TSA treatment
also resulted in significantly increased levels of citrullination
at H3R2+8+17 (Figure 4B-C). This observation further
Table 1 The effect of Cl-amidine on early embryonic
development
Group No. Stage of embryos (%)
1 Cell 2-4 Cell Morula
Cl-amidine 100 17 (17) 83 (83) 0 (0)
H-amidine 36 5 (13.9) 0 (0) 31(86.1)
KSOM 94 22 (23.4) 4 (4.3) 68 (72.3)
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suggests that there is a reinforcing relationship between
acetylation and citrullination and further highlights the po-
tential interplay between these two modifications on chro-
matin in preimplantation mammalian embryos.
Conclusions
This report is the first to document the presence of
citrullinated histones in mammalian oocytes and pre-
implantation embryos. The use of three site-specific
citrullinated histone antibodies found that histone
citrullination is likely playing several unique, yet to
be defined roles on chromatin templated events. We
found that the PADI inhibitor, Cl-amidine, potently
blocks embryonic development beyond the 4-cell
stage, thus further highlighting the important role of
PADIs in early development. This observation also
raises the possibility that PADI inhibitors could po-
tentially be utilized as novel contraceptives. Our study
also showed that Cl-amidine specifically suppressed
histone acetylation on the H3 and H4 tails while not
affecting levels of the transcriptionally repressive his-
tone H3K9 dimethyl modification. Further, we found
that induction of histone hyperacetylation leads to
enhanced histone citrullination. Mechanistically, as
with numerous other histone modifications [10,11],
these observations raise the distinct possibility that
(See figure on previous page.)
Figure 3 Effect of Cl-amidine and TSA treatment on histone H3 and H4 acetylation and methylation. A. PN zygotes were cultured for ~68
hours in KSOM medium supplemented with either 250 μM of Cl-amidine or 100 nM of TSA. Two or four-cell embryos were fixed and
immunostained with antibodies to hyperacetylated H4 (red) and acetyl H3K9 (green). DAPI was utilized to detect DNA (blue). DIC, differential
interference contrast. B. Histograms documenting the fluorescent intensity of the hyperacetylated H4 and acetyl H3K9 signals shown in A. C.
Same as (A) except antibodies against acetyl H3K18 (red) and di-methyl H3K9 (green) were used. D. Histograms documenting the fluorescent
intensity shown in B experiments. E. Same as (A) except antibodies against acetyl H4K5 (red) were used. F. Histogram documenting the
fluorescent intensity in experiment shown in E. Data are presented as mean+ SEM. *P< 0.05, **P< 0.005, ***P< 0.001 (two-tailed paired Student's
t-test).
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Figure 4 Potential crosstalk between histone citrullination and acetylation in early embryos. A. Colocalization of citrullinated
H3R2+ 8 + 17 and acetylated H3K9. Two-cell embryos were immuno-stained with antibodies to H3Cit2 + 8 + 17 (red) and H3acK9 (green). The
colocalization is highlighted in yellow in the merged panel. B. PN stage zygotes were co-cultured for ~68 hours in KSOM medium with 250 μM
of Cl-amidine or 100 nM of TSA. Two or four-cell embryos were fixed and immuno-stained with antibodies to H3Cit 2 + 8 + 17 (red). DAPI was
utilized to detect DNA (blue). DIC, differential interference contrast. Data are presented as mean+ SEM. *P< 0.05, (two-tailed paired Student's t-
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the citrulline modification on histones may function
as a “platform” for binding by histone acetyltrans-
ferases (HATs), thus facilitating transcriptional activa-
tion by enhancing levels of histone acetylation. More
detailed studies are now required to test this hypoth-
esis. We predict that outcomes from the current
study will likely lead to new and important insight
into epigenetic regulation of the oocyte to embryo
transition.
Methods
Animals
The generation of mouse mutants and genotyping strat-
egies for the Padi6 and Mater null strain has been
described previously [17,25]. To generate Padi4-null mice,
the entire genomic sequence of Padi4 was replaced in
frame with the coding sequence of LacZ and a Lox-flanked
neomycin gene driven by PGK-EM7 promoter. B6D2F1/J
and CD-1 mice were purchased from the Jackson Labora-
tory and Charles River Laboratories, respectively. All mice
were housed in the Cornell University Animal Facility
(Ithaca, NY) and procedures using these mice were
reviewed and approved by the Cornell University Institu-
tional Animal Care and Use Committee. Studies were per-
formed in accordance with the Guiding Principles for the
Care and Use of Laboratory Animals.
Oocyte and embryo collection
All experiments were performed using B6D2F1/J and CD-1
female mice (age 4-8 weeks) primed with gonadotrophins
(Sigma) to obtain fully-grown GV oocytes, ovulated
oocytes, and embryos (following mating with CD1 males).
All oocytes and embryos were collected in M2 medium
(Sigma) unless otherwise stated. Culture medium was sup-
plemented with 25 mM of milrinone (Sigma) to inhibit
GVBD. Embryos at different developmental stages were
collected and processed at different times.
Immunofluorescence and laser scanning confocal
microscopy
Indirect immunofluorescence labeling confocal micros-
copy was undertaken as described previously [26]. Rabbit-
anti-H4Cit3 (1:50, Abcam), rabbit-anti-H3Cit2 + 8+ 17
(1:50, Abcam), rabbit-anti-H3Cit26 (1:50, Abcam), rabbit-
anti-hyper acetyl H4 (1:50, Millipore), mouse-anti-acetyl
H3K9 (1:20, Abcam), rabbit-anti-acetyl H4K5 (1:50,
Abcam), rabbit-anti-acetyl H3K18 (1:50, Abcam), and
mouse-anti-dimethyl H3K9 (1:20, Abcam) antibodies were
used for this study. Images were obtained on LSM 510
laser scanning confocal microscopy (Carl Zeiss, Germany)
equipped with Zen 2007 software for image processing. In
the multicolor labeling experiments, the confocal config-
uration was set up to avoid the bleed-through of fluores-
cence dyes. To test for bleed-through, oocytes were
stained with each dye separately and images were taken
with multiple channels. Each signal was found to be well
resolved from other signals. Images for each developmen-
tal series were collected under similar conditions using the
following settings: ex= 555 nm, em=565 nm, laser power
12%, frame size 1024× 1024, scanning speed 7, averaging
number 4, detector gain around 700, digital offset around
-15, and Zen 2009 software. To directly compare changes
in signal intensity for embryos from different treatment
groups, confocal images were acquired under an identical
condition for those samples.
Embryo culture and drug treatment
The KSOM medium for embryo culture has been
described elsewhere [27].B6D2F1/J females were primed
with 10 IU PMSG (Sigma) followed by 10 IU hCG
(Sigma) injection, then housed with CD1 males. PN
zygotes were collected in M2 medium at ~26 hours post
hCG and cultured in KSOM for ~ 42 hours or 68 hours
supplemented with 250 μM of Cl-amidine, 250 μM of
H-amidine, or with 100 nM of TSA (Sigma). Embryos
cultured at 37 °C in an atmosphere of 5% CO2, 5% O2
and 90% N2 were fixed and immunostained with anti-
bodies at different time points for analyses. Digital
images were recorded on the confocal microscopy.
Citrulline antibody absorption assay by antigen peptide
All antibodies and antigen peptides were purchased from
Abcam with the exception of the H4Cit3 peptide which
was a kind gift from David Allis at Rockefeller University.
The ratios of antibody and peptide for H4Cit3, H3Cit2+8+
17, and H3Cit26 were 1mol:20 mols, 1μl:6 μls, and
1mol:40mols, respectively. The antibody and peptide were
added to the antibody dilution buffer (1% normal goat
serum, 0.5% BSA in PBS) and incubated on a rotator at
room temperature for 2 hours for the H4Cit3 and H3Cit2+
8+17 mixtures or for 1 hour (4°C) for the H3Cit26
mixture.
Deionized water replaced the histone modification pep-
tides as a control. GV-oocytes or 2-cell embryos were col-
lected from CD1 females at ~46 hours post PMSG
and~46 hours post hCG and processed for immunofluor-
escence and laser scanning confocal microscopy as
described above.
Nile red staining of mouse oocytes
Nile red powder (Sigma) was dissolved in DMSO to give a
stock solution of 1mg/ml and stored at -20°C. GV-oocytes
were collected in M2 media supplemented with IBMX
from Mater mutant females. After three quick washes in
PBS/PVA, oocytes were transferred into 4% paraformalde-
hyde/PBS and incubated for 30 min at room temperature.
Oocytes were briefly washed three times in PBS/PVA again
and transferred into nile red working solution (1μg/ml) for
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30 min following the fixation. After the nile red staining,
oocytes were washed three times and carefully added to the
drop of Slowfade Gold antifade reagent (Molecular probe)
on slides, and then a cover slide was placed on top of the
drop. Nile red fluorescence was captured by Laser Scanning
Confocal microscopy (Carl Zeiss).
Analysis of embryo viability
Pronuclear stage zygotes were retrieved from B6D2F1/J
females at ~26 hours post hCG and cultured for ~68 hours
in KSOM medium supplemented with 250 μM of Cl-
amidine or H-AM. Embryos from these two groups were
then incubated with 20 μg/ml of PI (Sigma) in KSOM for 5
min at 37 °C in an atmosphere of 5% CO2, washed 3 times,
and images were recorded using Zeiss epifluorescence mi-
croscopy (Carl Zeiss, Germany). A sub set of Cl-amidine
treated embryos were permeablized with 0.1% Triton for 20
min prior to PI staining to serve as positive control.
JC-1 staining of cultured embryos was performed
according to the Invitrogen protocol. Briefly, embryos
were stained with 10 μg/ml of JC-1(Invitrogen) in
KSOM for 10 min at 37 °C in an atmosphere of 5% CO2,
washed 3 times with KSOM, and images were captured
by Zeiss epifluorescence microscopy using fluorescein
isothiocyanate (FITC) and tetramethyl rhodamine iso-
thiocyanate (TRITC) filters.
Statistical analysis
All samples used for quantification included at least four
nuclei. Data were compiled and analyzed using Micro-
soft Excel 2007. Comparisons were made for the
intensity of histone modifications in embryos cultured in
KOSM media supplemented with or without Cl-amidine
using unpaired t-test. The threshold of statistical signifi-
cance was set at P< 0.05.
Additional files
Additional file 1: Localization of H3Cit26 to lipid droplets in mutant
Mater GV stage oocytes. Mutant Mater oocytes (which contain high
levels of lipid droplets) were probed with antibodies to H3Cit 26 (A) and
the oocytes were also stained with Nile Red (B). Confocal images were
taken of the stained oocytes following counterstaining with DAPI to
visualize DNA (blue). DIC, differential interference contrast.
Additional file 2: Peptide pre-absorption assay to test for antibody
specificity. Confocal images were taken of CD1 GV-stage oocytes stained
with H4Cit3 (A), H3Cit 2 + 8 + 17 (B) antibodies and 2-cell embryos
stained with H3Cit26 (C) antibodies. In top panels, deionized water was
used instead of the peptide solution as a control. In the bottom panels,
anti-citrullinated histone antibodies were pre-absorbed with cognate
peptides prior to staining oocytes and embryos. Oocytes/embryos were
counterstained with DAPI to visualize DNA (blue). DIC, differential
interference contrast.
Additional file 3: Comparison of citrullination levels at
H3R2+ 8+ 17, H4R3, and H3R26 in PADI6 wild-type and null
oocytes. Confocal images were taken of wild-type and PADI6-null GV
stage oocytes that had been probed with antibodies to H3Cit 2 + 8 + 17
(A), H4Cit3 (B), and H3Cit26 (C). Oocytes were counterstained with
DAPI to visualize DNA (blue). DIC, differential interference contrast.
Additional file 4: Comparison of citrullination levels at
H3R2+ 8+ 17 and H4R3 in PADI4 wild-type and null oocytes.
Confocal images were taken of wild-type and PADI4 null GV stage
oocytes that had been probed with antibodies to H3Cit2 + 8 + 17 (A) and
H4Cit3 (B). Oocytes were counterstained with DAPI to visualize DNA
(blue). DIC, differential interference contrast.
Additional file 5: Titration of Cl-amidine concentration for mouse
embryo culture study. A. Pronuclear stage zygotes were cultured for
~68 hours in KSOM medium supplemented without or with 500 nM, 5
μM, or 250 μM of Cl-amidine and images of the embryos were recorded
by light microscopy. Images were taken in 40X magnification with DIC
and the scale bar is 50 μm. B. Histogram showing the rate of embryonic
development for the different treatment groups in (A). (n) = total number
of embryos for each group. DIC, differential interference contrast.
Additional file 6: Assessment of embryo viability following Cl-
amidine treatment. Pronuclear stage zygotes were cultured for ~68
hours in KSOM medium supplemented with 250 μM of Cl-amidine or H-
amidine prior to the staining. A. Propidium iodide (PI) staining of
cultured embryos. Embryos were stained with 20 μg/ml of PI in KSOM for
5 min and images were recorded by epifluorescence microscopy. Cl-
amidine treated embryos were treated with 0.1% Triton for 20 min prior
to PI staining and utilized as positive control to show the nuclear staining
of nonviable cells. Propidium iodide, PI. B. JC-1 staining of embryos
following treatment with Cl-amidine or H-amidine. Embryos were stained
with 10 μg/ml of JC-1 in KSOM for 10 min and fluorescence was
captured by epifluorescence microscopy. DIC, differential interference
contrast.
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